Literature DB >> 10923826

Studies on adsorption characteristics of bile acids and methotrexate to a new type of anion-exchange resin, colestimide.

Y Honda1, M Nakano.   

Abstract

The adsorption characteristics of various bile acids and methotrexate to a new type of anion-exchange resin, colestimide, were studied in vitro and compared with those to cholestyramine. For bile acids, colestimide was shown to have a higher capacity than cholestyramine. For example, approximately 1.4-fold higher for cholic acid and 2.0-fold for deoxycholic acid in water. In the presence of physiological anions, the degree of adsorption of cholic acid to both resins was greatly reduced, whereas adsorption of deoxycholic acid was only slightly reduced. Furthermore, the bed-volume of colestimide swelled about 6.8-fold in water, hence the anion-exchange groups of this resin are expected to be able to function effectively in adsorption of bile acids in the gut. In addition, colestimide was found to have high adsorption capacity for methotrexate, not only in water but also in media containing various physiological anions, and thus it is suggested that colestimide is a potential oral antidote to reduce possible toxicity by methotrexate through interruption of enterohepatic circulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10923826     DOI: 10.1248/cpb.48.978

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  2 in total

1.  Twin-Arginine Translocation System Is Involved in Citrobacter rodentium Fitness in the Intestinal Tract.

Authors:  Tsuyoshi Otake; Mayuka Fujimoto; Yusuke Hoshino; Tomomi Ishihara; Takeshi Haneda; Nobuhiko Okada; Tsuyoshi Miki
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

2.  Tat-exported peptidoglycan amidase-dependent cell division contributes to Salmonella Typhimurium fitness in the inflamed gut.

Authors:  Mayuka Fujimoto; Ryosuke Goto; Riku Hirota; Masahiro Ito; Takeshi Haneda; Nobuhiko Okada; Tsuyoshi Miki
Journal:  PLoS Pathog       Date:  2018-10-31       Impact factor: 6.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.